Aquinox Pharma (AQXP) Misses Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
Aquinox Pharmaceuticals Announces First Quarter 2016 Financial Results
May 10, 2016 9:06 AM EDTVANCOUVER, British Columbia, May 10, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (Aquinox) (NASDAQ: AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, today... More
